We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites.AuthorsVadhan-Raj, S; Cordon-Cardo, C; Carswell, E; Mintzer, D; Dantis, L; Duteau, C; Templeton, M A; Oettgen, H F; Old, L J; Houghton, A NPublicationJournal of Clinical Oncology, 1988, Vol 6, Issue 10, p1636ISSN0732-183xPublication typearticleDOI10.1200/jco.1988.6.10.1636